GlassScriptPhysician profile
John C Gibbons
NPI 1902398845
$820.69
in general payments reported to CMS, 2019-2025
20 companies · $274 in 2025
The $274 reported for 2025 was more than what a typical Physical Medicine & Rehabilitation provider received nationally (typical 2025 total: $138).
See the full distribution for Physical Medicine & Rehabilitation
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $14.28 · 2022: $198 · 2023: $209 · 2024: $126 · 2025: $274.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $609.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $608.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $190.96 | 2022-2025 | |
| Allergan, INC. | $103.00 | 2022 | |
| Merz Pharmaceuticals, LLC | $71.89 | 2025 | Xeomin |
| Otsuka America Pharmaceutical, INC. | $62.51 | 2023 | Rexulti, Nuedexta |
| Avanir Pharmaceuticals, INC. | $48.04 | 2022 | |
| Idorsia Pharmaceuticals US INC | $44.43 | 2022-2024 | Quviviq |
| Collegium Pharmaceutical, INC. | $41.01 | 2025 | Belbuca |
| Ani Pharmaceuticals, INC. | $28.77 | 2023 | Purified Cortrophin Gel |
| Octapharma USA, INC. | $26.76 | 2025 | Octagam Immune Globulin (Human) |
| Averitas Pharma INC. | $25.57 | 2024 | Qutenza |
| Corium, LLC | $22.70 | 2023 | Azstarys |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $22.67 | 2023 | Relistor |
| Amgen INC. | $21.61 | 2023 | Prolia, Evenity |
| Ipsen Biopharmaceuticals, INC | $20.42 | 2023 | Dysport |
| Lundbeck LLC | $17.68 | 2024 | Vyepti |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Valinor Pharma, LLC | $16.38 | 2025 | Movantik |
| Almatica Pharma LLC | $14.72 | 2025 | Loreev Xr |
| Tonix Medicines, INC. | $14.55 | 2025 | Tonmya |
| Bayer Healthcare Pharmaceuticals INC. | $14.28 | 2021 | |
| Pfizer INC. | $12.74 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Gibbons listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.